Referencias bibliográficas

  1. Wu C, Duan X, Wang X, Wang L. Advances in the role of epigenetics in homocysteine-related diseases. Epigenomics. 2023 Aug;15(15):769-795.
  2. McCaddon A, Miller JW. Homocysteine-a retrospective and prospective appraisal. Front Nutr. 2023 Jun 13;10:1179807
  3. Kubo Y, Shoji K, Tajima A, Horiguchi S, Fukuoka H, Nishikawa M, Kagawa Y, Kawabata T. Serum 5-Methyltetrahydrofolate Status Is Associated with One-Carbon Metabolism-Related Metabolite Concentrations and Enzyme Activity Indicators in Young Women. Int J Mol Sci. 2023 Jul 1;24(13):10993.
  4. Kaul S, Zaheh AA, Shah PK. Homocysteine hypothesis for atherothrombotic cardiovascular disease. JACC 2006;48(5):914-23.
  5. de Groot PG, Willems C, Boers GH, Gonsalves MD, van Aken WG, van Mourik JA.Endothelial cell dysfunction in homocystinuria. Eur J Clin Invest 1983; 13: 405-10.
  6. Perna, Alessandra & Ingrosso, Diego & Lombardi, Cinzia & Acanfora, Filomena & Satta, Ersilia & Cesare, Concetta & Violetti, Eleonora & Romano, Maria & Natale Gaspare, De Santo. (2003). Possible mechanisms of homocysteine toxicity. Kidney international. Supplement. 63. S137-40. 10.1046/j.1523-1755.63.s84.33.x.
  7. Villar-Fidalgoa, M., del Rey-Sánchez, J M., Boix-Martínez, R, Matíes-Prats, M.  Prevalencia de la hiperhomocisteinemia y factores asociados en atención primaria. Med Clin (Barc). 2005;125(13):487-92
  8. Kim J, Kim H, Roh H, Kwon Y. Causes of hyperhomocysteinemia and its pathological significance. Arch Pharm Res. 2018 Apr;41(4):372-383.
  9. Homocysteine Studies Collaboration. Homocysteine and risk of ischemic heart disease and stroke: A meta-analysis. JAMA 2002:288:2015-22.
  10. den Heijer M, Koster T, Blom HJ, et al. Hyperhomocysteinemia as a risk factor for deep-vein thrombosis. N Engl J Med 1996; 334: 759-62.
  11. Harpel PC, Chang VT, Borth W. Homocysteine and other sulfhydryl compounds enhance the binding of lipoprotein(a) to fibrin: a potential biochemical link between thrombosis, atherogenesis, and sulfhydryl compound metabolism. Proc Natl Acad Sci USA 1992; 89; 10193-7.
  12. Naruszewicz M, Mirkiewicz E, Olszewski AJ, et al. Thiolation of low-density lipoprotein by homocysteine thiolactone causes increased aggregation and altered interaction with cultured macrophages. Nutr Metab Cardiovasc Dis 1994; 4: 70-77
  13. González Juanatey JR, Cordero A, Vitale GC, González Timón B, Mazón P, Bertomeu V. Magnitude and characteristics of residual lipid risk in patients with a history of coronary revascularization: The ICP-Bypass Study. Rev Esp Cardiol 2011;64:862-8
  14. SANCHEZ, C. et al. Vitaminas B y homocisteína en la insuficiencia renal crónica. Nutr. Hosp. [online]. 2007, vol.22, n.6 [citado  2023-10-23], pp.661-671.
  15. Robinson K, Gupta A, Dennis VW y cols. Hyperhomocisteinemia confers an independent increased risk of atherosclerosis in ende-stage renal disease and is closely linked to plasma folate and pyridoxine concentrations. Circulation 1996; 94:2743-2748.
  16. Eikelboom JW, Lonn E, Genest J, Jr., Hankey G, Yusuf S: Homocyst(e)ine and cardiovascular disease: a critical review of the epidemiologic evidence. Ann Intern Med 1999; 131: 363-375.
  17. SUAREZ GARCIA, I. et al . La homocisteína: ¿El factor de riesgo cardiovascular del próximo milenio?. An. Med. Interna (Madrid),  v. 18, n. 4, p. 53-59,  abr.  2001.
  18. Dai C, Fei Y, Li J, Shi Y, Yang X. A Novel Review of Homocysteine and Pregnancy Complications. Biomed Res Int. 2021 May 6;2021:6652231.
  19. Ronnenberg AG, Venners SA, Xu X, Chen C, Wang L, Guang W, Huang A, Wang X. Preconception B-vitamin and homocysteine status, conception, and early pregnancy loss. Am J Epidemiol. 2007 Aug 1;166(3):304-12.
  20. López-Quesada EL, Vilaseca MA, González S. Homocisteína y gestación. Med Clin (Barc) 2000;115:352-6
  21. Mascarenhas, M.; Habeebullah, S.; Sridhar, M.G. Revisiting the Role of First Trimester Homocysteine as an Index of Maternal and Fetal Outcome. J. Pregnancy 2014, 2014, 123024.
  22. D.M. Kado, A.S. Karlamangla, M.H. Huang, A. Troen, J.W. Rowe, J. Selhub, et al. Homocysteine versus the vitamins folate, B6, and B12 as predictors of cognitive function and decline in older high-functioning adults: MacArthur Studies of Successful Aging. Am J Med, 118 (2005), pp. 161-167
  23. E. Joosten, E. Lesaffre, R. Riezler, V. Ghekiere, L. Dereymaeker, W. Pelemans, et al. Is metabolic evidence for vitamin B-12 and folate deficiency more frequent in elderly patients with Alzheimer’s disease?. J Gerontol A Biol Sci Med Sci, 52 (1997), pp. M76-M79
  24. I.R. Bell, J.S. Edman, J. Selhub, F.D. Morrow, D.W. Marby, H.L. Kayne, et al. Plasma homocysteine in vascular disease and in nonvascular dementia of depressed elderly people. Acta Psychiatr Scand, 86 (1992), pp. 386-390
  25. Applebaum J., H. Shimon, B.A. Sela, R.H. Belmaker, J. Levine. Homocysteine levels in newly admitted schizophrenic patients. J Psychiatr Res, 38 (2004), pp. 413-416
  26. A.M. Troen. The central nervous system in animal models of hyperhomocysteinemia. Prog Neuropsychopharmacol Biol Psychiatry, 29 (2005), pp. 1140-1151
  27. Nuño-Ayala, Mario, Ricardo Carnicer, Mario Alberto Guzmán, Natalia Guillén, María Ángeles Navarro, Carmen Arnal, and Jesús Osada. “Hiperhomocisteinemia. Panorama Actual y Contribución Del Ratón a Su Estudio.” Clínica e Investigación En Arteriosclerosis 22, no. 5 (2010): 200–219.
  28. Boushey CJ, Beresford SA, Omenn GS, Motulsky AG. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. J. Am. Med. Assoc. 1995;74:1049–57.
  29. Toole JF, Malinow MR, Chambless LE, Spence JD, Pettigrew LC, et al. Lowering Homocysteine in Patients With Ischemic Stroke to Prevent Recurrent Stroke, Myocardial Infarction, and Death: The Vitamin Intervention for Stroke Prevention (VISP) Randomized Controlled Trial. J. Am. Med. Assoc. 2004;291:565–75.
  30. McMahon JA, Green TJ, Skeaff CM, Knight RG, Mann JI, et al. A controlled trial of homocysteine lowering and cognitive performance. N. Engl. J. Med. 2006;354:2764–72.
  31. Sato Y, Honda Y, Iwamoto J, Kanoko T, Satoh K. Effect of folate and mecobalamin on hip fractures in patients with stroke: a randomized controlled trial. J. Am. Med. Assoc. 2005;293:1082–8.